← Back to Search

Occupational Therapy for Kidney Cancer

N/A
Waitlist Available
Led By Sumanta K Pal
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 and over.
Sufficiently fluent in English.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 5 and 12 weeks
Awards & highlights

Study Summary

This study is evaluating whether occupational therapy can help reduce fatigue in patients with renal cell cancer.

Eligible Conditions
  • Kidney Cancer
  • Renal Cell Carcinoma

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 5 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 5 and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Anxiety
Depression
Fatigue Inventory Score
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (OT, questionnaires)Experimental Treatment2 Interventions
Patients participate in OT sessions weekly for 3 weeks over 30 minutes each. Patients also complete questionnaires to assess anxiety, depression, fatigue and pain at baseline, 5 and 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Occupational Therapy
2011
Completed Phase 3
~1230

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
558 Previous Clinical Trials
1,917,451 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,607 Previous Clinical Trials
40,914,162 Total Patients Enrolled
Sumanta K PalPrincipal InvestigatorCity of Hope Medical Center
9 Previous Clinical Trials
353 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Jun 2024